TARO
Taro Pharmaceutical Industries

260
Loading...
Loading...
Latest Earnings Results: Q3 '23
Reported: May 20

Estimated EPS

$0.30

Reported EPS

$0.54

Surprise

+80%

Estimated Rev

$154.91M

Reported Rev

$157.15M

Surprise

+1.44%

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '23
$0.31
$0.40
29.03%
BEAT
Q3 '23
$0.30
$0.54
80.00%
BEAT
Q2 '23
$0.18
$0.23
27.78%
BEAT
Q1 '23
$0.31
$0.27
-12.90%
MISSED

Latest TARO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.